Directorate Change

RNS Number : 3118D
AstraZeneca PLC
12 September 2008
 



ASTRAZENECA PLC APPOINTS NEW NON-EXECUTIVE DIRECTOR


AstraZeneca today announced that Rudy Markham is to join the Board of Directors as a Non-Executive Director with immediate effect. Rudy Markham was formerly Chief Financial Officer of Unilever. He is currently a Non-Executive Director of Legal and General Group Plc, Standard Chartered PLC and United Parcel Service, Inc. He is also a member of Board of the Financial Reporting Council.


Louis Schweitzer, Chairman of AstraZeneca said: 'We are delighted that Rudy Markham has agreed to join us. His considerable experience of over 35 years at Unilever, latterly in finance, will be invaluable to the work of the Board and the Audit Committee.'


No disclosure obligations arise under paragraph (1) to (6) of Listing Rule 9.6.13 of the UK Listing Authority's Listing Rules in respect of the appointment of Rudy Markham.



About AstraZeneca

AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.



Media Enquiries:

Neil McCrae                  +44 207 304 5045 (24 hours)

Chris Sampson             +44 20 7304 5130 (24 hours)    


Investor Enquiries UK:

Jonathan Hunt               +44 207 304 5087      mob: +44 7775 704032

Mina Blair                     +44 20 7304 5084      mob: +44 7718 581021

Karl Hard                      +44 207 304 5322      mob: +44 7789 654364


Investor Enquiries US:

Ed Seage                              +1 302 886 4065      mob: +1 302 373 1361

Jorgen Winroth                       +1 212 579 0506      mob: +1 917 612 4043

Peter Vozzo (MedImmune)      +1 301 398 4358      mob: +1 301 252 7518



12 September 2008



- Ends -


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASFASAESASELU

Companies

AstraZeneca (AZN)
UK 100